Skip Navigation

Press Releases

Anemia News Items

Filter Press Releases

April 6, 2017

Media Availability: NHLBI researchers available to discuss recent findings and ongoing research addressing health disparities

WHAT: April is National Minority Health Month and experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss recent findings and ongoing research projects about health conditions and social determinants that disproportionately affect racial and ethnic minorities and low income populations.

Health disparities are differences in the incidence, prevalence, mortality, and burden of diseases and other adverse health conditions that exist among specific population groups in the United States.

November 17, 2015

Specific dosage of sickle cell drug increases survival rate

WHAT: An analysis by National Institutes of Health researchers has shown that people with sickle cell anemia who took the drug hydroxyurea at the recommended dose had higher survival rates than those who took less than the recommended dose. The findings appear in the journal PLOS ONE.

July 1, 2015

Largest Study of Gene Mutations in Aplastic Anemia May Help Optimize Treatment

Scientists have identified a group of genetic mutations in patients with aplastic anemia, which likely will help doctors optimize treatment for this rare and deadly blood condition. The study, appearing in the New England Journal of Medicine, could lead to tailor-made treatment plans for aplastic anemia patients as part of the emerging precision medicine movement. It is the largest study of its kind to examine gene mutations in aplastic anemia, the scientists note.

September 16, 1997

NHLBI to Announce Sickle Cell Clinical Alert at Press Conference

The National Heart, Lung, and Blood Institute (NHLBI) will hold a press conference on Thursday, September 18, 1997, at 10:00 a.m. to announce the results of an important clinical trial involving the prevention of strokes in children with sickle cell anemia.

Page 1 of 1


  • 1